These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11139972)

  • 21. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
    Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing sudden death in coronary cardiomyopathy: implantable defibrillators lead the way.
    Pavia S; Wilkoff BL
    Cleve Clin J Med; 2001 Feb; 68(2):113, 118, 120, 121, 125, 129. PubMed ID: 11220454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and risk evaluation for sudden cardiac death in ischaemic and non-ischaemic cardiomyopathy: results of the European Heart Rhythm Association survey.
    Proclemer A; Lewalter T; Bongiorni MG; Svendsen JH; Pison L; Lundqvist CB;
    Europace; 2013 Jul; 15(7):1059-62. PubMed ID: 23794672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Arrhythmias during remodeling after myocardial infarction].
    Bauer WR; Ertl G
    Herz; 2002 Dec; 27(8):740-9. PubMed ID: 12574891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol.
    Schuger C; Daubert JP; Brown MW; Cannom D; Estes NA; Hall WJ; Kayser T; Klein H; Olshansky B; Power KA; Wilber D; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2012 Jul; 17(3):176-85. PubMed ID: 22816536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.
    Kaiser DW; Tsai V; Heidenreich PA; Goldstein MK; Wang Y; Curtis J; Turakhia MP;
    Heart Rhythm; 2015 Oct; 12(10):2086-93. PubMed ID: 25982720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do women benefit equally as men from the primary prevention implantable cardioverter-defibrillator?
    Barra S; Providência R; Boveda S; Narayanan K; Virdee M; Marijon E; Agarwal S
    Europace; 2018 Jun; 20(6):897-901. PubMed ID: 29016772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MADIT-II: substudies and their implications.
    Moss AJ;
    Card Electrophysiol Rev; 2003 Dec; 7(4):430-3. PubMed ID: 15071269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compliance to MADIT and MUSTT criteria for implantable cardioverter defibrillator therapy in the pre-SCD-Heft and MADIT II era. Data from a multicenter Italian study.
    Cappato R; Zanotto G; Menozzi C; Coppola A; Curnis A; Freggiaro V; Sanna T; Sinagra G; Pizzetti F; Sermasi S; Locatelli A; Zaccone G; Pecora D; Raciti G; Accardi F
    Int J Cardiol; 2010 Oct; 144(2):268-9. PubMed ID: 19232761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving sudden cardiac death risk stratification by evaluating electrocardiographic measures of global electrical heterogeneity and clinical outcomes among patients with implantable cardioverter-defibrillators: rationale and design for a retrospective, multicenter, cohort study.
    Waks JW; Hamilton C; Das S; Ehdaie A; Minnier J; Narayan S; Niebauer M; Raitt M; Tompkins C; Varma N; Chugh S; Tereshchenko LG
    J Interv Card Electrophysiol; 2018 Jun; 52(1):77-89. PubMed ID: 29541969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators.
    Santangeli P; Di Biase L; Dello Russo A; Casella M; Bartoletti S; Santarelli P; Pelargonio G; Natale A
    Ann Intern Med; 2010 Nov; 153(9):592-9. PubMed ID: 21041579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function?
    Block M; Hammel D; Böcker D; Borggrefe M; Breithardt G
    Am J Cardiol; 1996 Sep; 78(5A):62-8. PubMed ID: 8820838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
    Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study.
    Proclemer A; Muser D; Campana A; Zoni-Berisso M; Zecchin M; Locatelli A; Brieda M; Gramegna L; Santarone M; Chiodi L; Mazzone P; Rebellato L; Facchin D
    Int J Cardiol; 2013 Sep; 168(2):1416-21. PubMed ID: 23287697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden cardiac death and implantable cardioverter defibrillators: two modern epidemics?
    Katritsis DG; Josephson ME
    Europace; 2012 Jun; 14(6):787-94. PubMed ID: 22308081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.